TY - JOUR
T1 - Cardiac Glycosides. 6. Gitoxigenin C16 Acetates, Formates, Methoxycarbonates, and Digitoxosides. Synthesis and Na+,K+-ATPase Inhibitory Activities
AU - Hashimoto, Toshihiro
AU - Rathore, Hargovind
AU - Hong, George
AU - Fullerton, Dwight S.
AU - Satoh, Daisuke
AU - Griffin, Jane F.
AU - From, Arthur H.L.
AU - Ahmed, Khalil
PY - 1986
Y1 - 1986
N2 - A series of 17 gitoxigenin 16β-formates, acetates, and methoxycarbonates was synthesized, including their 3β-acetates, formates, and digitoxosides. A 16β-formate group was generally found to increase activity 30 times, a 16β-acetate group 9–12 times, while a 16β-methoxycarbonate decreased activity by two-thirds. 3β-Formates and acetates had little effect on activity by themselves, but sometimes reduced the activity-increasing properties of 160-formates and acetates. A 3β-digitoxoside increases the activity of gitoxigenin by 15 times, but the effect is less if the 160-group is esterified. And finally, a 16-one decreases activity dramatically. These data suggest an important role for C16 esters and possibly the presence of a separate binding site on Na+,K+-ATPase corresponding to the cardenolide C16 position.
AB - A series of 17 gitoxigenin 16β-formates, acetates, and methoxycarbonates was synthesized, including their 3β-acetates, formates, and digitoxosides. A 16β-formate group was generally found to increase activity 30 times, a 16β-acetate group 9–12 times, while a 16β-methoxycarbonate decreased activity by two-thirds. 3β-Formates and acetates had little effect on activity by themselves, but sometimes reduced the activity-increasing properties of 160-formates and acetates. A 3β-digitoxoside increases the activity of gitoxigenin by 15 times, but the effect is less if the 160-group is esterified. And finally, a 16-one decreases activity dramatically. These data suggest an important role for C16 esters and possibly the presence of a separate binding site on Na+,K+-ATPase corresponding to the cardenolide C16 position.
UR - http://www.scopus.com/inward/record.url?scp=0022502772&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0022502772&partnerID=8YFLogxK
U2 - 10.1021/jm00156a017
DO - 10.1021/jm00156a017
M3 - Article
C2 - 3012087
AN - SCOPUS:0022502772
SN - 0022-2623
VL - 29
SP - 997
EP - 1003
JO - Journal of Medicinal Chemistry
JF - Journal of Medicinal Chemistry
IS - 6
ER -